Clinical Trial Update: Study of Zonisamide in Early Parkinson Disease [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating zonisamide in early Parkinson disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Zonisamide (zonisamide)

Snippet

Sponsor: Mazandaran University of Medical Sciences | Conditions: Parkinson Disease | Phase 2, Phase 3 | Status: WITHDRAWN